top of page
GlomCon Logo V7 - Black100-percent.png
Kidney Topics
Clinical Trials

  • Clinical trials are research studies conducted to evaluate new treatments, medications, or medical devices. They are crucial to advancing medical knowledge and improving patient care. Participating in clinical trials can provide access to innovative therapies that may not yet be widely available for patients with kidney disease.

    • Clinical trials are essential for:

      1. Developing New Treatments: They help researchers determine whether new medications or therapies are safe and effective.

      2. Improving Existing Therapies: Trials can test whether existing treatments work better when combined or used differently.

      3. Advancing Medical Knowledge: The data collected from clinical trials contributes to a better understanding diseases and how to manage them.

      4. Providing Early Access to New Therapies: Patients who participate in clinical trials may gain access to cutting-edge treatments before they are approved for general use.

    • 1. Treatment Trials

      • Purpose: To test new treatments, such as medications, dialysis techniques, or surgical procedures.

      • Example: A study evaluating a new drug that slows the progression of chronic kidney disease (CKD).

       

      2. Prevention Trials

      • Purpose: To find ways to prevent kidney disease or its complications.

      • Example: Research whether lifestyle changes or supplements can prevent kidney damage in people with diabetes.

       

      3. Diagnostic and Screening Trials

      • Purpose: To improve methods for diagnosing or detecting kidney disease earlier.

      • Example: A trial testing a new biomarker that can identify kidney disease before symptoms appear.

       

      4. Quality of Life Trials

      • Purpose: To explore ways to improve the quality of life for people with kidney disease.

      • Example: Studies on mental health interventions or dietary changes for dialysis patients.

    • Clinical trials typically go through four phases before a treatment is approved for widespread use:

      ​

      Phase 1: Safety and Dosage

      • Participants: A small group of healthy volunteers or patients.

      • Purpose: To assess the safety of the treatment and determine the appropriate dosage.

      ​

      Phase 2: Efficacy and Side Effects

      • Participants: A larger group of patients with the condition.

      • Purpose: To evaluate the treatment's effectiveness and gather more information on side effects.

      ​

      Phase 3: Comparison and Monitoring

      • Participants: Hundreds to thousands of patients.

      • Purpose: To compare the new treatment with standard treatments and monitor its effectiveness and safety over time.

      ​

      Phase 4: Post-Marketing Surveillance

      • Participants: Patients using the treatment after it has been approved.

      • Purpose: To monitor long-term effects and gather information on the treatment’s use in real-world settings.

    • Every clinical trial has specific criteria that participants must meet. These are known as inclusion and exclusion criteria, and they ensure that the study results are accurate and meaningful.

       

      Inclusion Criteria

      These are the conditions that a participant must meet to join the trial, such as:

      • Age range.

      • Stage of kidney disease.

      • Medical history.

      ​

      Exclusion Criteria

      These are factors that disqualify a person from participating, such as:

      • Certain health conditions that could interfere with the study.

      • Use of specific medications.

    • Benefits

      1. Access to New Treatments: Participants may receive innovative therapies before they are widely available.

      2. Close Monitoring: Patients in clinical trials often receive more frequent check-ups and monitoring than during standard care.

      3. Contributing to Medical Advances: Patients help researchers develop better treatments for future generations by participating.

      ​

      Risks

      1. Unknown Side Effects: Since new treatments are still being studied, risks or side effects may not yet be known.

      2. No Guaranteed Benefit: The tested treatment may not be more effective than existing options.

      3. Time Commitment: Participating in a clinical trial may require frequent visits, tests, and follow-ups.

    • If you are considering participating in a clinical trial, ask your healthcare provider or the research team the following questions:

      1. What is the purpose of the trial?

      2. What treatments or interventions will I receive?

      3. What are the potential risks and benefits?

      4. How long will the trial last?

      5. Will I need to pay for any part of the treatment?

      6. How will my privacy be protected?

      7. Can I leave the trial if I change my mind?

  • The clinical trial process is rigorous and carefully designed to ensure safety and efficacy before any new drug, therapy, or medical device is released into the market.

    • Before a clinical trial can involve human participants, extensive preclinical research is conducted in laboratories.

      ​

      • Laboratory Studies: Researchers study potential treatments using cells and tissues to understand how they work and whether they are likely effective.

      • Animal Studies: If the lab results are promising, researchers test the treatment in animals to gather more information about its safety and effectiveness.

      ​

      Preclinical research aims to determine whether a treatment is safe enough to proceed to human testing. If successful, researchers submit their findings to regulatory bodies (like the FDA) to request permission to begin clinical trials.

    • Clinical trials are conducted in four phases, each with a specific purpose and participant group.

      Phase
      Participants
      Purpose
      What Happens
      Outcome
      Phase 1: Safety and Dosage
      20-100 healthy volunteers or patients.
      To assess the safety of the treatment and determine the appropriate dosage.
      Participants receive the therapy in gradually increasing doses while researchers monitor for side effects.
      If the treatment is deemed safe, it moves to Phase 2.
      Phase 2: Efficacy and Side Effects
      100-300 patients with the condition being studied.
      To determine how well the treatment works and gather more information on its safety.
      Participants are closely monitored for improvements in their condition and any adverse effects.
      If the treatment shows promise, it advances to Phase 3.
      Phase 3: Comparison and Monitoring
      300-3,000 patients.
      To compare the new treatment to standard treatments and evaluate its safety and effectiveness.
      Participants are randomly assigned to receive either the new or standard treatment (or placebo) in a controlled environment.
      Positive results lead to submission for regulatory approval.
      Phase 4: Post-Marketing Surveillance
      Thousands of patients using the treatment after it has been approved.
      To monitor long-term effects and gather data on how the treatment performs in real-world settings.
      Researchers continue collecting data on side effects, effectiveness, and new issues.

    • Once Phase 3 is complete, researchers compile all the data and submit it to regulatory authorities, such as:

      ​

      • The U.S. Food and Drug Administration (FDA).

      • The European Medicines Agency (EMA).

      • Other national regulatory bodies.

      ​

      Regulatory agencies review the data to ensure the treatment is safe and effective. If approved, the treatment can be marketed and prescribed to patients.

    • Even after a treatment is approved, monitoring ensures long-term safety and efficacy. This may include:

      ​

      • Phase 4 Trials: Additional studies to gather long-term data.

      • Pharmacovigilance: Reporting and tracking adverse events.

      • Registry Studies: Collecting real-world evidence from large groups of patients using the treatment.

    • Ethics play a vital role in every step of the clinical trial process. Key ethical principles include:

      ​

      1. Informed Consent: Before agreeing to participate, participants must be fully informed about the trial, including potential risks and benefits.

      2. Institutional Review Boards (IRBs): Independent committees review and approve clinical trial protocols to ensure participant safety.

      3. Transparency: Researchers must report accurate data and disclose any conflicts of interest.

    • Patients play a central role in clinical trials, and their participation is essential for medical progress. Before joining a trial, patients should:

      • Understand the purpose of the trial.

      • Be aware of the potential risks and benefits.

      • Know their rights, including the ability to withdraw at any time.

  • Clinical trials are crucial in advancing medical science, yet many people hesitate to participate due to misconceptions. Understanding the difference between myths and realities can help patients make informed decisions about joining a clinical trial.

    • Reality: While some clinical trials are designed for patients with advanced or treatment-resistant conditions, many trials are open to individuals at earlier stages of a disease or even those who are healthy. There are various types of trials, including prevention, diagnostic, and quality-of-life studies, which can benefit a broad range of participants.

    • Reality: Clinical trials are conducted under strict ethical guidelines and oversight to protect participants. Before a trial begins, it must be approved by an Institutional Review Board (IRB), which ensures that the study is ethical and that participants' rights and well-being are prioritized. Participants are fully informed about the trial and must provide consent before joining.

    • Reality: Placebos are rarely used alone in clinical trials for serious diseases. Most trials compare a new treatment to the current standard of care, meaning participants will receive the new treatment or the best available treatment. If a placebo is used, it is typically combined with standard treatment so that no participant is left without care.

    • Reality: Safety is the top priority in clinical trials. Extensive preclinical research is conducted before human testing begins. During the trial, participants are closely monitored, and trials are designed to minimize risks. Additionally, regulatory agencies like the FDA oversee clinical trials to ensure they are as safe as possible.

    • Reality: Participants can leave a clinical trial at any time and for any reason. Participation is entirely voluntary, and patients can withdraw if they feel uncomfortable or their circumstances change. Researchers encourage open communication and respect a participant's decision to exit a trial.

    • Reality: While some clinical trials take place in major hospitals and research institutions, many are also conducted in local clinics, community hospitals, and private practices. Advances in technology have also enabled remote or virtual clinical trials, making participation more accessible to people in different locations.

    • Reality: In most cases, participants do not have to pay to join a clinical trial. The trial sponsor typically covers the cost of the treatment, tests, and procedures related to the study. Some trials may even compensate participants for their time and travel expenses. However, it is essential to ask the research team about potential costs before enrolling.

    • Reality: Participants in clinical trials often receive a higher level of care than they would outside of a trial. This is because a dedicated team of healthcare professionals closely monitors them. Frequent check-ups and tests ensure any issues are detected and addressed promptly.

    • Reality: Clinical trials are open to people of all ages, depending on the study's criteria. There are trials specifically designed for children, adults, and older adults. Having diverse participants, including older adults, is important to ensure that treatments are effective for everyone.

    • Reality: Even after a treatment is approved, clinical trials continue. Phase 4 trials (post-marketing surveillance) are conducted to monitor long-term safety and effectiveness, gather additional data, and explore new uses for the treatment. This ongoing research ensures that approved treatments remain safe and beneficial.

  • Informed consent is a process through which potential participants learn about a clinical trial in detail and voluntarily decide whether to join. It is designed to protect participants by ensuring they have all the information they need to make an educated decision about their involvement.

    ​

    Informed consent is not a one-time event but an ongoing process. Throughout the trial, participants can ask questions and receive updated information.

    • Informed consent ensures:

      1. Transparency: Participants are fully aware of what the trial involves.

      2. Autonomy: Individuals can make voluntary decisions about their participation without coercion.

      3. Protection: By understanding the potential risks and benefits, participants can weigh whether the trial is right for them.

      4. Ethical Standards: Informed consent upholds ethical principles in medical research, ensuring respect for participants.

    • When reviewing an informed consent form, participants should expect the following key components:

       

      1. Purpose of the Trial

      • A clear explanation of the trial’s goals, such as testing a new medication, therapy, or medical device.

       

      2. Description of Procedures

      • Detailed information about what will happen during the trial, including tests, treatments, and the study duration.

       

      3. Potential Risks and Benefits

      • Access to new treatments may be included in an outline of possible risks, such as side effects and potential benefits.

       

      4. Alternatives to Participation

      • Information about other treatment options or procedures available outside the trial.

       

      5. Confidentiality

      • Ensure that personal and medical information will be kept confidential and used only for research purposes.

       

      6. Voluntary Participation

      • This statement emphasizes that participation is voluntary and that participants can withdraw from the trial without penalty or loss of medical care.

       

      7. Contact Information

      • Details on contacting the research team with questions or concerns during the trial.

    • Before signing an informed consent form, consider the following steps:

      1. Take Your Time

        • Don’t feel rushed to make a decision. Review the form carefully and discuss it with your family, friends, or healthcare provider.

      2. Ask Questions

        • If anything is unclear, ask the research team for clarification. Some important questions to consider include:

          • What are the potential side effects?

          • How often will I need to visit the clinic?

          • Will there be any costs involved?

          • How will my privacy be protected?

      3. Understand Your Rights

        • Remember that participation is entirely voluntary, and you can leave the trial anytime for any reason.

      4. Discuss with Your Healthcare Provider

        • Your doctor can help you weigh the pros and cons of participating in the trial based on your medical condition.

    • Informed consent doesn’t end once you sign the form. Throughout the trial, you will receive updates about new findings, procedure changes, or emerging risks. You may be asked to sign a revised consent form if significant changes occur.

    • 1. Signing the form means you have to complete the trial.

      • Reality: You can leave the trial anytime without penalty or impact on your standard medical care.

       

      2. Informed consent guarantees there are no risks.

      • Reality: While the consent form outlines known risks, unforeseen risks may still occur. The research team will monitor your health closely to manage any potential issues.

       

      3. Informed consent means the treatment is guaranteed to work.

      • Reality: Clinical trials are designed to test new treatments. Because effectiveness cannot be guaranteed, trials are conducted.

      1. What is the primary purpose of the trial?

      2. What are the potential benefits and risks?

      3. How long will the trial last?

      4. What procedures or tests will I need to undergo?

      5. How will my privacy be protected?

      6. What happens if I want to leave the trial early?

      7. Are there any costs involved, or will I be compensated?

1689680803-huge.jpg
GOT QUESTIONS?
Share your concerns confidentially and get expert insights from a nephrologist during our PACE meeting. 
bottom of page